Literature DB >> 570882

Enhanced metabolism and mutagenesis of nitrosopyrrolidine in liver fractions isolated from chronic ethanol-consuming hamsters.

G D McCoy, C H Chen, S S Hecht, E C McCoy.   

Abstract

The effect of chronic ethanol consumption on the ability of isolated liver fractions to metabolize the carcinogen N-nitrosopyrrolidine (NPY) was examined. Microsomal fractions of treated animals exhibited increased rates of alpha-hydroxylation of NPY. Similar increases in the specific activities of aniline hydroxylase, reduced nicotinamide adenine dinucleotide phosphate cytochrome c reductase, and the specific content of cytochrome P-450 were also observed. In contrast, no differences in the specific activities of benzo(a)pyrene hydroxylase or glucose-6-phosphatase were observed. Liver postmitochondrial supernatants from ethanol-consuming animals were able to produce 5 times more mutants than did control preparations. It is concluded that alpha-hydroxylation of NPY is probably the mechanism by which NPY is converted to a mutagen and that this pathway can be induced by ethanol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 570882

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Cancer risks derived from alcohol.

Authors:  A J Tuyns
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

Review 2.  Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.

Authors:  Yupeng Li; Stephen S Hecht
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Effect of alcohol ingestion on carcinogenesis by synthetic estrogen and progestin in the rat liver.

Authors:  K Yamagiwa; S Higashi; R Mizumoto
Journal:  Jpn J Cancer Res       Date:  1991-07

4.  Tumor enhancers: underestimated factors in the epidemiology of lifestyle-associated cancers.

Authors:  E L Wynder
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.